BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 1312271)

  • 21. Progression from papilloma to carcinoma is accompanied by changes in antibody response to papillomavirus proteins.
    Lin YL; Borenstein LA; Selvakumar R; Ahmed R; Wettstein FO
    J Virol; 1993 Jan; 67(1):382-9. PubMed ID: 7677955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccination of rabbits with an adenovirus vector expressing the papillomavirus E2 protein leads to clearance of papillomas and infection.
    Brandsma JL; Shlyankevich M; Zhang L; Slade MD; Goodwin EC; Peh W; Deisseroth AB
    J Virol; 2004 Jan; 78(1):116-23. PubMed ID: 14671093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region.
    Kondo K; Ishii Y; Ochi H; Matsumoto T; Yoshikawa H; Kanda T
    Virology; 2007 Feb; 358(2):266-72. PubMed ID: 17010405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant Listeria monocytogenes vaccination eliminates papillomavirus-induced tumors and prevents papilloma formation from viral DNA.
    Jensen ER; Selvakumar R; Shen H; Ahmed R; Wettstein FO; Miller JF
    J Virol; 1997 Nov; 71(11):8467-74. PubMed ID: 9343203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccinia virus-expressed bovine ephemeral fever virus G but not G(NS) glycoprotein induces neutralizing antibodies and protects against experimental infection.
    Hertig C; Pye AD; Hyatt AD; Davis SS; McWilliam SM; Heine HG; Walker PJ; Boyle DB
    J Gen Virol; 1996 Apr; 77 ( Pt 4)():631-40. PubMed ID: 8627251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incorporation of RG1 epitope concatemers into a self-adjuvanting Flagellin-L2 vaccine broaden durable protection against cutaneous challenge with diverse human papillomavirus genotypes.
    Kalnin K; Chivukula S; Tibbitts T; Yan Y; Stegalkina S; Shen L; Cieszynski J; Costa V; Sabharwal R; Anderson SF; Christensen N; Jagu S; Roden RBS; Kleanthous H
    Vaccine; 2017 Sep; 35(37):4942-4951. PubMed ID: 28778613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Orf Virus-Based Therapeutic Vaccine for Treatment of Papillomavirus-Induced Tumors.
    Schneider M; Müller M; Yigitliler A; Xi J; Simon C; Feger T; Rziha HJ; Stubenrauch F; Rammensee HG; Iftner T; Amann R
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32404527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human papillomavirus vaccines.
    Breitburd F; Coursaget P
    Semin Cancer Biol; 1999 Dec; 9(6):431-44. PubMed ID: 10712890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral immunization using tuber extracts from transgenic potato plants expressing rabbit hemorrhagic disease virus capsid protein.
    Martín-Alonso JM; Castañón S; Alonso P; Parra F; Ordás R
    Transgenic Res; 2003 Feb; 12(1):127-30. PubMed ID: 12650532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunization with potato plants expressing VP60 protein protects against rabbit hemorrhagic disease virus.
    Castañón S; Marín MS; Martín-Alonso JM; Boga JA; Casais R; Humara JM; Ordás RJ; Parra F
    J Virol; 1999 May; 73(5):4452-5. PubMed ID: 10196345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plant-produced cottontail rabbit papillomavirus L1 protein protects against tumor challenge: a proof-of-concept study.
    Kohl T; Hitzeroth II; Stewart D; Varsani A; Govan VA; Christensen ND; Williamson AL; Rybicki EP
    Clin Vaccine Immunol; 2006 Aug; 13(8):845-53. PubMed ID: 16893983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of L1, infectious virions and anti-L1 antibody in domestic rabbits infected with cottontail rabbit papillomavirus.
    Hu J; Budgeon LR; Cladel NM; Culp TD; Balogh KK; Christensen ND
    J Gen Virol; 2007 Dec; 88(Pt 12):3286-3293. PubMed ID: 18024897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rabbits immunised with recombinant BCG expressing the cottontail rabbit papillomavirus (CRPV) L2E7E2 genes induces regression of established papillomas.
    Govan VA; Williamson AL
    Virus Res; 2007 Jul; 127(1):43-8. PubMed ID: 17451831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.
    Kirnbauer R; Booy F; Cheng N; Lowy DR; Schiller JT
    Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12180-4. PubMed ID: 1334560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection.
    Mason PW; Pincus S; Fournier MJ; Mason TL; Shope RE; Paoletti E
    Virology; 1991 Jan; 180(1):294-305. PubMed ID: 1845826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on vaccination against papillomaviruses: prophylactic and therapeutic vaccination with recombinant structural proteins.
    Jarrett WF; Smith KT; O'Neil BW; Gaukroger JM; Chandrachud LM; Grindlay GJ; McGarvie GM; Campo MS
    Virology; 1991 Sep; 184(1):33-42. PubMed ID: 1651594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of dengue virus structural proteins and nonstructural protein NS1 by a recombinant vaccinia virus.
    Zhao BT; Prince G; Horswood R; Eckels K; Summers P; Chanock R; Lai CJ
    J Virol; 1987 Dec; 61(12):4019-22. PubMed ID: 3316711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant capripoxvirus expressing the hemagglutinin protein gene of rinderpest virus: protection of cattle against rinderpest and lumpy skin disease viruses.
    Romero CH; Barrett T; Chamberlain RW; Kitching RP; Fleming M; Black DN
    Virology; 1994 Oct; 204(1):425-9. PubMed ID: 8091673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection of rabbits against cutaneous papillomavirus infection using recombinant tobacco mosaic virus containing L2 capsid epitopes.
    Palmer KE; Benko A; Doucette SA; Cameron TI; Foster T; Hanley KM; McCormick AA; McCulloch M; Pogue GP; Smith ML; Christensen ND
    Vaccine; 2006 Jun; 24(26):5516-25. PubMed ID: 16725236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination of cattle with bovine papillomavirus type 4 L2 elicits the production of virus-neutralizing antibodies.
    Gaukroger JM; Chandrachud LM; O'Neil BW; Grindlay GJ; Knowles G; Campo MS
    J Gen Virol; 1996 Jul; 77 ( Pt 7)():1577-83. PubMed ID: 8758002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.